The SP post deal would depend upon a number of factors some of...

The SP post deal would depend upon a number of factors some of which are:

1 - Upfront Cash Amount and Ongoing Royalties Percentage
2 - Market (Geographical) for which deal is signed
3 - The Partner in question (how big they are)
4 - Whether the various approvals (FDA, EU, etc) will be done by TIS or the Partner
5 - The lenght of the agreement (in years)
6 - Whether its an exclusive agreement or doors open for more
7 - Whether its for VitroGro for Diabetic Ulcers only or for more pipeline products

and a few more in the list ....

If all boxes are ticked in favor of TIS - the SP could be well north of $2 or 3 within a couple of weeks of the deal. But thats unlikely.

I wouldnt want to do the permutations here on what kind of deal can be signed because there are plenty of combinations.

Nonetheless, I do think that we should get to a market cap atleast twice of now after a first deal is signed (based on the permutations i think are most likely). The market has definately priced in a deal in the SP .. but not to a large extent. Most of the price jumps were after Good Clinical Results and Patent grants. There is still a lot of room in the SP for a potential multiplication on the announcement of a deal.

I am forcing myself to not call for a SP post deal - but in my opinion i'd say $1.50+ within the week is what im expecting.

The above is my opinion only - no advice given or intended. - DYOR